You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cong Xu1, Yonghong Xu2, Ling Gao3
1School of Clinical Medicine, Dali University, Dali, Yunnan, 671000, People's Republic of China.
Fibroblast growth factor 5 (FGF5) is a novel potential biomarker for stroke risk. Inflammatory factors and metabolites like GPE mediate stroke occurrence, offering new targets for intervention.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: